Last 9.25 GBp
Change Today -0.25 / -2.63%
Volume 309.5K
EDEN On Other Exchanges
Symbol
Exchange
London
OTC US
As of 11:35 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

eden research plc (EDEN) Snapshot

Open
9.50 GBp
Previous Close
9.50 GBp
Day High
9.50 GBp
Day Low
9.25 GBp
52 Week High
12/2/14 - 13.00 GBp
52 Week Low
11/12/14 - 6.88 GBp
Market Cap
12.3M
Average Volume 10 Days
368.2K
EPS TTM
--
Shares Outstanding
133.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EDEN RESEARCH PLC (EDEN)

Related News

No related news articles were found.

eden research plc (EDEN) Related Businessweek News

No Related Businessweek News Found

eden research plc (EDEN) Details

Eden Research Plc develops and markets intellectual property, primarily in the area of terpenes and other health-related projects in the United Kingdom. The company provides products in the areas of foliar disease control, soil pests, protected glass house crops, post harvest applications, and vascular disease control. It offers 3AEY, a terpene based fungicide; and develops various products for the control of botrytis, powdery mildew, nematodes, spider mites, and whiteflies, as well as vascular diseases, such as esca, eutypa, and pierce's disease. The company was formerly known as Ximed Group plc and changed its name to Eden Research Plc as a result of the merger with Eden Research Inc in 2003. Eden Research Plc is headquartered in Witney, the United Kingdom.

6 Employees
Last Reported Date: 06/6/14

eden research plc (EDEN) Top Compensated Officers

Chief Financial Officer, Director and Member ...
Total Annual Compensation: 95.0K GBP
Business Development Director and Director
Total Annual Compensation: 43.3K GBP
Compensation as of Fiscal Year 2013.

eden research plc (EDEN) Key Developments

Eden Research plc Provides Update on Authorization of 3AEY

Eden Research plc announced that it has commented on the draft registration report from the regulatory authorities in Malta in relation to its review of the application for the authorization of 3AEY, Eden's agrochemical product which is used to tackle botrytis, a fungal disease affecting many plants, including grapes. The company has provided comprehensive responses to points raised by the Maltese authorities. The Maltese authorities will next collate all comments received and then advise Eden whether or not all of the information that has been submitted by Eden is sufficient for authorization of 3AEY. Once authorization has been given by Malta, the remaining Southern EU zone member states will have 120 days in which to issue their authorizations. Eden, its advisors and its licensees fully expect authorization in due course, following the processes and requirements of the regulatory authorities.

Eden Research PLC Reports Consolidated Earnings Results for the Six Months Ended June 30, 2014

Eden Research PLC reported consolidated earnings results for the six months ended June 30, 2014. For the period, the company reported group revenue of GBP 18,000 against GBP 49,000 a year ago. Operating loss was GBP 878,000 against GBP 711,000 a year ago. Loss on ordinary activities before taxation and loss for the financial period was GBP 1,295 million against GBP 713,000 a year ago. Basic and diluted loss per share was 1.05 pence against 0.59 pence a year ago. Net cash used in operating activities was 515,000 against GBP 1,019,000 a year ago. Capitalisation of development expenditure was 215,000 against GBP 24,000 a year ago.

Eden Research PLC to Report First Half, 2014 Results on Sep 29, 2014

Eden Research PLC announced that they will report first half, 2014 results on Sep 29, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EDEN:LN 9.25 GBp -0.25

EDEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EDEN.
View Industry Companies
 

Industry Analysis

EDEN

Industry Average

Valuation EDEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 218.0x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 272.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDEN RESEARCH PLC, please visit www.edenresearch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.